Brief: Roquefort Therapeutics Says MDK Oncology Antibodies Demonstrate In-Vivo Safety
24/01/2023 08:00
Jan 24 (Reuters) - Roquefort Therapeutics PLC ROQ.L :
* ROQUEFORT THERAPEUTICS PLC - MDK ONCOLOGY ANTIBODIES
DEMONSTRATE
IN-VIVO SAFETY
Source text for Eikon: ID:
Further company coverage: ROQ.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coiled Therapeutics
See all newsRCS - Coiled Therapeutics - Investor Presentation via Engage Investor
RCS - Coiled Therapeutics - Participation in The Small Cap Showcase
Coiled Therapeutics - Director/PDMR Shareholding
Coiled Therapeutics - Interim Results to 30 June 2026
Coiled Therapeutics - Successful Enrolment Completed Across Two Cohorts